Clincosm LogoSign in Get a demo

Delivery Systems

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 1, Delivery Systems Trial in Chieti (NovoFine® needle 6 mm, NovoFine® needle 8 mm)

Completed
  • Diabetes
  • +2 more
  • NovoFine® needle 6 mm
  • NovoFine® needle 8 mm
  • Chieti, Italy
    Novo Nordisk Investigational Site
Aug 3, 2018

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (FlexTouch®, FlexPen®)

Completed
Has Results
  • Diabetes
  • +3 more
  • FlexTouch®
  • FlexPen®
  • Burlingame, California
  • +64 more
Feb 6, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Neuss (19 injections, sodium chloride 0.9% solution)

Completed
Has Results
  • Diabetes
  • +3 more
  • 19 injections
  • sodium chloride 0.9% solution
  • Neuss, Germany
    Novo Nordisk Investigational Site
Jan 18, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Århus (NovoFine® needle 6 mm, NovoFine® needle 12 mm)

Completed
  • Diabetes
  • +3 more
  • NovoFine® needle 6 mm
  • NovoFine® needle 12 mm
  • Århus, Denmark
    Novo Nordisk Investigational Site
Feb 27, 2017

Growth Hormone Disorder, Growth Hormone Deficiency in Children, Foetal Growth Problem Trial in Paris La défense cedex

Completed
Has Results
  • Growth Hormone Disorder
  • +8 more
  • Norditropin NordiFlex®
  • Paris La défense cedex, France
    Novo Nordisk Investigational Site
Jan 12, 2017

Diabetes, Healthcare Professionals, Delivery Systems Trial in København (NovoFine® needle 8 mm, autocover needle)

Completed
  • Diabetes
  • +2 more
  • NovoFine® needle 8 mm
  • autocover needle
  • København, Denmark
    Novo Nordisk Investigational Site
Feb 22, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Ålborg, Århus C (NovoFine® needle 6 mm, NovoFine® needle 4 mm)

Completed
  • Diabetes
  • +3 more
  • NovoFine® needle 6 mm
  • NovoFine® needle 4 mm
  • Ålborg, Denmark
  • +1 more
Feb 6, 2017

NovoPen Echo® on Safety and Treatment Satisfaction in Children

Completed
  • Diabetes
  • +2 more
  • NovoPen Echo®
  • Mississauga, Canada
  • +4 more
Feb 6, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United States (NovoFine® needle 6 mm, Ultra-Fine needle 12.7 mm)

Completed
  • Diabetes
  • +3 more
  • NovoFine® needle 6 mm
  • Ultra-Fine needle 12.7 mm
  • Walnut Creek, California
  • +4 more
Jan 18, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in United Kingdom (NovoFine® needle 6 mm, NovoFine® needle 8 mm)

Completed
  • Diabetes
  • +3 more
  • NovoFine® needle 6 mm
  • NovoFine® needle 8 mm
  • Cambridge, United Kingdom
  • +9 more
Jan 18, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (NovoPen™ 4, NovoPen® 3)

Completed
  • Diabetes
  • +3 more
  • NovoPen™ 4
  • NovoPen® 3
  • Wien, Austria
  • +22 more
Jan 18, 2017

Diabetes, Diabetes, Type 2, Delivery Systems Trial in San Antonio (FlexPen®, vial and syringe)

Completed
  • Diabetes
  • +2 more
  • FlexPen®
  • vial and syringe
  • San Antonio, Texas
    Novo Nordisk Investigational Site
Jan 5, 2017

Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2

Completed
  • Diabetes
  • +2 more
  • biphasic insulin aspart 30
  • Jakarta, Indonesia
    Novo Nordisk Investigational Site
Dec 12, 2016

NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type

Completed
  • Diabetes
  • +3 more
  • NovoPen® 4
  • Beijing, Beijing, China
    Novo Nordisk Investigational Site
Nov 22, 2016

Norditropin NordiFlex® With NordiFlex PenMate™

Completed
  • Growth Hormone Disorder
  • +2 more
  • NordiFlex PenMate™
  • Mainz, Germany
  • +3 more
Nov 16, 2016

Evaluation of Safety and Parameters of Application Technique

Completed
  • Diabetes
  • +3 more
  • No treatment given
  • Bratislava, Slovakia
    Novo Nordisk Investigational Site
Nov 4, 2016

Assess the Efficacy and Safety of NovoRapid™ Flexpen™

Completed
  • Diabetes
  • +3 more
  • insulin aspart
  • Manilla, Philippines
    Novo Nordisk Investigational Site
Oct 26, 2016

Diabetes, Diabetes, Type 2, Delivery Systems Trial in United States (pump, insulin aspart)

Completed
  • Diabetes
  • +2 more
  • pump
  • insulin aspart
  • Chula Vista, California
  • +5 more
Oct 17, 2016

Diabetes, Healthcare Professionals, Delivery Systems Trial in Plainsboro (safety glide, autocover needle)

Completed
  • Diabetes
  • +2 more
  • safety glide
  • autocover needle
  • Plainsboro, New Jersey
    Novo Nordisk Investigational Site
Oct 17, 2016

Diabetes, Diabetes, Type 2, Delivery Systems Trial in Århus C (pump, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • +2 more
  • pump
  • +2 more
  • Århus C, Denmark
    Novo Nordisk Investigational Site
Oct 14, 2016

NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice

Completed
  • Diabetes
  • +3 more
  • FlexPen®
  • NovoPen® 3
  • Karachi, Pakistan
    (unnamed)
Jun 11, 2015

Usability and Tolerability of Norditropin NordiFlex® Injection

Completed
  • Growth Hormone Disorder
  • +8 more
  • Norditropin NordiFlex®
  • Paris La défense cedex, France
    (unnamed)
Jun 23, 2014